A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2024-08-08 DOI:10.3324/haematol.2024.285313

Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im, Robert L Redner, Kathleen A Dorritie, Mounzer Agha, Jing-Zhou Hou, Rafic Farah, James Rossetti, Daniel P Normolle, Theresa L Whiteside, Yen-Michael Sheng Hsu, Michael Boyiadzis

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

针对老年急性髓性白血病患者的 pembrolizumab 缓解后治疗 II 期研究。

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.

文献相关原料

公司名称	产品信息	采购帮参考价格